Thoracic Radiochemoimmunotherapy for Non-Small Cell Lung Cancer (NSCLC): Evolving Techniques and Clinical Applications
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Oncology".
Deadline for manuscript submissions: 31 March 2026 | Viewed by 29
Special Issue Editor
Special Issue Information
Dear Colleagues,
Thoracic radiotherapy is a cornerstone in the treatment of lung cancer patients. With rapid advancements in imaging technologies and precision-based radiotherapy techniques, modern oncology continues to evolve toward more individualized and effective and less invasive care. This Special Issue will cover the most clinically relevant topics in the field of NSCLC with respect to radical radiation treatment combined with immunochemotherapy.
Individualized approaches in the context of tailored therapies rely on sophisticated radiation technologies combined with translational molecular research. Hence, with a technical focus, this Special Issue will place emphasis on the integration of artificial intelligence, functional imaging (PET-CT), stereotactic radiation techniques, particle therapy for centrally located tumors, and MRT as a new image-guidance modality.
We welcome articles presenting findings from original research, clinical trials, real-world data, and reviews that reflect the latest trends and challenges radiation-based therapies, ultimately contributing to improved patient outcomes.
Dr. Franz Zehentmayr
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- radiotherapy
- radiology
- oncology
- non-small cell lung cancer
- real-world data
- immunotherapy
- radiation dose escalation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
